A recent report discusses a newly developed immunotherapy for allergies that avoids the need for long-term allergen injections to desensitize the immune system to the allergy-producing substances. Researchers at Genoa University, Italy, say tests of the new immunotherapy tablets, which are placed under the tongue for a short period of time and then swallowed, showed that participants randomized to receive the tablet showed significantly lower levels of allergy symptoms than those who received placebos following treatment for 12 and 24 months. The report is in The Lancet.